Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 2/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.40 |
| ▸ | OPRD1 | P41143 | 8/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | CCR2 | P41597 | 1/20 | 0.40 |
| ▸ | F11 | P03951 | 1/20 | 0.39 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3341720 | 0.93 | DPP4 (0.44) | MEN1KMT2ADPP4DPP8DPP9 | |
| SCHEMBL1790205 | 0.93 | OPRM1 (0.43) | MEN1KMT2AOPRM1OPRD1OPRK1 | |
| Trifluoroacetic Acid SCHEMBL3340025 | 0.90 | OPRM1 (0.47) | DPP4DPP8DPP9DPP7OPRM1 | |
| SCHEMBL12607786 | 0.86 | OPRM1 (0.45) | MEN1KMT2AOPRM1OPRD1OPRK1 | |
| Trifluoroacetic Acid SCHEMBL3338278 | 0.85 | OPRM1 (0.50) | MEN1KMT2ADPP4DPP8DPP9 | |
| Trifluoroacetic Acid SCHEMBL3345285 | 0.83 | OPRM1 (0.46) | DPP4DPP8DPP9DPP7BACE1 | |
| Trifluoroacetic Acid SCHEMBL3345226 | 0.83 | GRIN2B (0.50) | DPP4DPP8DPP9DPP7BACE1 | |
| SCHEMBL1788728 | 0.82 | OPRM1 (0.52) | OPRM1OPRD1OPRK1FAAH | |
| Trifluoroacetic Acid SCHEMBL16194723 | 0.82 | DPP4 (0.42) | DPP4DPP8DPP9DPP7OPRM1 | |
| Trifluoroacetic Acid SCHEMBL3339667 | 0.81 | DPP4 (0.42) | DPP4DPP8DPP9DPP7OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140323487-A1 | Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors | GLAXOSMITHKLINE LLC | 2014-10-30 | — | — | US | disclosed |
| US-20100113512-A1 | METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | IGNAR DIANE MICHELE | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113512-A1 | METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | OPRL1, OPRD1, OPRK1 | MEN1 4375/4885KMT2A 2191/4885DPP4 1431/4885 |
| US-20140323487-A1 | Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors | OPRL1, OPRM1, OPRK1 | MEN1 4865/4885KMT2A 3867/4885DPP4 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.